Massachusetts Eye and Ear and Massachusetts General Hospital advancied gene-based COVID-19 vaccine
On May 5, 2020, Massachusetts Eye and Ear and Massachusetts General Hospital (MGH), members of Mass General Brigham,…
-
-
LabCorp announced availability of COVID-19 antibody test
On May 5, 2020, LabCorp announced that its COVID-19 Immunoglobulin G (IgG) antibody test is now available for…
-
Pfizer and BioNTech dosed first participants in US as part of global COVID-19 mRNA vaccine development program
On May 5, 2020, Pfizer and BioNTech announced the first participants have been dosed in the U.S. in…
-
Athersys announced commencement of patient enrollment in MACOVIA Study, a pivotal phase 2/3 trial evaluating MultiStemﾮ cell therapy for COVID-19 induced ARDS
On May 5, 2020, Athersys announced the first patients have been enrolled in Athersysﾒ pivotal Phase 2/3 study…
-
Diffusion Pharma announced FDA Accelerated Review of TSC clinical development plan to treat COVID-19 patients with ARDS
On May 5, 2020, Diffusion Pharmaceuticals announced the FDA accelerated its review of the Companyﾒs clinical development plan…
-
ACON Laboratories announced international availability of SARS-CoV-2 rapid test
On May 5, 2020, ACON Laboratories announced the availability of its SARS-COV-2 IgG/IgM Rapid Test. ACONﾒs test is…
-
Biotechnology | COVID-19 | Diagnostics | FDA
FDA provided Emergency Use Authorization to PerkinElmer for serological test to identify COVID-19 antibodies
On May 5, 2020, PerkinElmer announced the FDA provided Emergency Use Authorization (EUA) for EUROIMMUN’s (a PerkinElmer company)…
-
Medigen Vaccine Biologics signed a license agreement with NIH on COVID-19 vaccine
On May 5, 2020, Medigen Vaccine Biologics (MVB) announced a global commercial license agreement with National Institutes of…
-
Biotechnology | COVID-19 | Diagnostics | Medical Device | Non-Profit Research | Pharmaceutical | Therapeutics
USPTO launched platform to facilitate connections between patent holders and potential licensees in key technologies
On May 4, 2020, the U.S. Patent and Trademark Office (USPTO) unveiled a new web-based intellectual property marketplace…
-
Biotechnology | COVID-19 | FDA
BIOFIRE respiratory panel 21 (RP21) with SARS-CoV-2 obtained FDA Emergency Use Authorization
On May 4, 2020, bioMerieux announced that BioFire Diagnostics, its subsidiary specialized in syndromic infectious disease testing, has…
-
Vir and Alnylam identified RNAi therapeutic development candidate, VIR-2703 (ALN-COV), targeting SARS-CoV-2 for treatment of COVID-19
On May 4, 2020, Vir Biotech and Alnylam Pharma announced the selection of a development candidate for VIR-2703,…
-
Anixa Biosciences and OntoChem announced discovery of first Covid-19 therapeutic candidate
On May 4, 2020, Anixa Biosciences and partner OntoChem, announced they had identified its first therapeutic candidate against…
-
NanoViricides signed confidential disclosure agreement with international pharma company to explore collaboration on COVID-19 program
On May 4, 2020, NanoViricides announced that it has signed a Confidential Disclosure Agreement with a leading pharmaceutical…
-
Eli Lilly and Junshi Biosciences to co-develop antibody therapies for pevention and treatment of COVID-19
On May 4, 2020, Junshi Biosciences and Eli Lilly announced an agreement to co-develop therapeutic antibodies for the…
-
Mayo Clinic received $26 million from BARDA for COVID-19 convalescent plasma expanded access program
On May 4, 2020, Mayo Clinic was awarded a $26 million contract from the Biomedical Advanced Research and…
-
Arcturus Therapeutics and Catalent announced partnership to manufacture mRNA-Based COVID-19 vaccine
On May 4, 2020, Arcturus Therapeutics and Catalent announced a partnership to support the expected manufacture of Arcturusﾒ…
-
AbCellera identified antibodies for potential use in drugs to treat and prevent COVID-19
On May 3, 2020, AbCellera announced it had received a commitment of up to $175.6 million in support…
-
Moderna and Lonza announced worldwide strategic collaboration to manufacture Moderna’s Vaccine (mRNA-1273) against novel Coronavirus
On May 1, 2020, Moderna and Lonza announced a 10-year strategic collaboration agreement to enable larger scale manufacture…
-
CHF Solutions shipped Aquadex product to COVID-19 specialty center in Minnesota
On May 1, 2020, CHF Solutions announced that it has shipped Aquadex product to a specialty care center…
-
Cancer patients face high mortality from COVID-19
On May 1, 2020, people with cancer who develop COVID-19 are much more likely to die from the…
-
Athersys and University Hospitals Cleveland Medical Center announce activation of first clinical site for MACOVIA study for COVID-19 Induced ARDS
On May 1, 2020, Athersys and University Hospitals Cleveland Medical Center (UH Cleveland) announced that UH Cleveland is…
-
XBiotech identified ‘super bloods’ for development of True Human COVID-19 therapy
On May 1, 2020, XBiotech announced that human immune donors had been identified that can support the Company’s…
-
COVID-19 | FDA | Therapeutics
Gilead announced investigational antiviral remdesivir received FDA Emergency Use Authorization for treatment of COVID-19
On May 1, 2020, Gilead announced the FDA granted emergency use authorization (EUA) for the investigational antiviral remdesivir…
-
FDA issued Emergency Use Authorization for potential COVID-19 treatment
On May 1, 2020, the FDA issued an Emergency Use Authorization (EUA) for the investigational antiviral drug remdesivir…
-
USC study showed Alzheimer’s gene triggers early breakdowns in the blood-brain barrier, predicting cognitive decline
On May 1, 2020, a University of Southern California (USC) study suggested that temporarily suppressing the body’s immune…
-
CDC launched the National Healthcare Safety Network COVID-19 Module Data Dashboard
On May 1, 2020, the CDC launched the National Healthcare Safety Network (NHSN) COVID-19 Module Data Dashboard showing…
-
US Dept of Veterans Affairs participated in drug, plasma trials in fight against COVID-19
On May 1, 2020, the U.S. Dept. of Veterans Affairs (VA) announced participation in a series of clinical…
-
CDC launched national viral genomics consortium to better map SARS-CoV-2 transmission
On May 1, 2020, the CDC launched the SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance…
-
Landmark partnership announced for development of COVID-19 vaccine
On Apr. 30, 2020, the University of Oxford announced an agreement with the UK-based global biopharmaceutical company AstraZeneca…
-
City of Hope began CIRM-funded Coronavirus study
On Apr. 30, 2020, The California Institute for Regenerative Medicine (CIRM) awarded $750,000 to City of Hopeﾒs John…
